Company: ZLAB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001704292-25-000024
Chunk: 35

Company: Zai Lab Ltd
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 35
---
Item 1. Financial Statements.

Zai Lab Limited 

Unaudited Condensed Consolidated Balance Sheets 

(in thousands of U.S. dollars (“$”), except for number of shares and per share data) 

NotesSeptember 30,2025December 31,2024AssetsCurrent assetsCash and cash equivalents3717,155 449,667 Restricted cash, current100,000 100,000 Short-term investments— 330,000 Accounts receivable (net of allowance for credit losses of $25 as of both September 30, 2025 and December 31, 2024, respectively)85,377 85,178 Notes receivable19,628 4,233 Inventories, net467,135 39,875 Prepayments and other current assets43,653 41,527 Total current assets1,032,948 1,050,480 Restricted cash, non-current1,115 1,114 Property and equipment, net548,868 47,961 Operating lease right-of-use assets15,751 21,496 Land use rights, net2,852 2,907 Intangible assets, net655,278 56,027 Other non-current assets2,128 5,768 Total assets1,158,940 1,185,753 Liabilities and shareholders’ equity  Current liabilities  Accounts payable99,706 100,906 Current operating lease liabilities5,496 8,048 Short-term debt10203,026 131,711 Other current liabilities1151,541 58,720 Total current liabilities359,769 299,385 Deferred income28,061 31,433 Non-current operating lease liabilities10,840 13,712 Other non-current liabilities325 325 Total liabilities398,995 344,855 Commitments and contingencies (Note 17)  Shareholders’ equity  Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized; 1,113,299,160 and 1,082,614,740 shares issued as of September 30, 2025 and December 31, 2024, respectively; 1,105,865,950 and 1,077,702,540 shares outstanding as of September 30, 2025 and December 31, 2024, respectively)